Ruthenium coordination compounds of biological and biomedical significance. DNA binding agents

被引:136
作者
Brabec, Viktor [1 ]
Kasparkova, Jana [1 ]
机构
[1] Czech Acad Sci, Inst Biophys, Kralovopolska 135, CZ-61265 Brno, Czech Republic
关键词
Ruthenium; DNA binding; Photoactivation; Radiosensitization; Cytotoxicity; CELL-FREE MEDIA; ARENE ANTICANCER COMPLEX; G-QUADRUPLEX DNA; II POLYPYRIDYL COMPLEXES; AMINO-OXIME LIGANDS; DOUBLE-HELICAL DNA; IN-VITRO; GROOVE-BINDING; METAL-COMPLEXES; SUPRAMOLECULAR CYLINDERS;
D O I
10.1016/j.ccr.2018.07.012
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Ruthenium complexes exhibit a broad variety of biological and biomedical activities including anticancer efficiency. The reason is that the octahedral bonding of both Ru(II) and Ru(III) complexes affords an extensive repertoire of three-dimensional architectures, giving the potential for a high degree of site selectivity for binding to their biological targets. The mechanism of biological and biomedical action of ruthenium compounds is connected with their interactions with biomacromolecules. A lot of mechanistic studies revealed disposition of many ruthenium complexes to operate via mechanisms of action involving interactions with DNA, but distinctly different from those of the approved platinum anticancer drugs. In this Review, we discuss major DNA binding modes hitherto identified for ruthenium complexes of biological or biomedical significance and provide some typical examples. The introduction provides the reader with a brief overview of the approaches in the search for the new, transition metal-based agents of biological or biomedical significance to provide the context in which more recent research of DNA binding of ruthenium complexes has been evolved. We then describe main categories of binding modes between DNA and ruthenium compounds, such as coordinative, intercalative, minor groove binding, sequence specificity of DNA binding, the ability of ruthenium compounds to condense and cleave DNA, binding to A- and Z-DNA, DNA quadruplexes and other unusual DNA structures. A number of complexes based on ruthenium(II) centers have been reported to have excellent photophysical and radiosensitizing properties so that DNA photocleavage and synergistic enhancement of DNA damage due to a combined action of ruthenium complexes and ionizing radiation is also discussed. Finally, inhibition of DNA processing enzymes is reviewed as well. We believe that such a synthesis of disparate DNA binding modes of ruthenium complexes will help to generate new ruthenium complexes of improved biological and biomedical significance. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 94
页数:20
相关论文
共 141 条
  • [1] Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy
    Abid, Mohammad
    Shamsi, Farheen
    Azam, Amir
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (10) : 772 - 786
  • [2] Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity
    Adhireksan, Zenita
    Davey, Gabriela E.
    Campomanes, Pablo
    Groessl, Michael
    Clavel, Catherine M.
    Yu, Haojie
    Nazarov, Alexey A.
    Yeo, Charmian Hui Fang
    Ang, Wee Han
    Droege, Peter
    Rothlisberger, Ursula
    Dyson, Paul J.
    Davey, Curt A.
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [3] In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer
    Aird, RE
    Cummings, J
    Ritchie, AA
    Muir, M
    Morris, RE
    Chen, H
    Sadler, PJ
    Jodrell, DI
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (10) : 1652 - 1657
  • [4] Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
    Alessio, Enzo
    [J]. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2017, (12) : 1549 - 1560
  • [5] Metal complexes as photo- and radiosensitizers
    Ali, H
    van Lier, JE
    [J]. CHEMICAL REVIEWS, 1999, 99 (09) : 2379 - 2450
  • [6] BINDING MODES AND BASE SPECIFICITY OF TRIS(PHENANTHROLINE)RUTHENIUM(II) ENANTIOMERS WITH NUCLEIC-ACIDS - TUNING THE STEREOSELECTIVITY
    BARTON, JK
    GOLDBERG, JM
    KUMAR, CV
    TURRO, NJ
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1986, 108 (08) : 2081 - 2088
  • [7] Hydrogen Bonding and Anticancer Properties of Water-Soluble Chiral p-Cymene RuII Compounds with Amino-Oxime Ligands
    Benabdelouahab, Yosra
    Munoz-Moreno, Laura
    Frik, Malgorzata
    de la Cueva-Alique, Isabel
    El Amrani, Mohammed Amin
    Contel, Maria
    Bajo, Ana M.
    Cuenca, Tomas
    Royo, Eva
    [J]. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2015, (13) : 2295 - 2307
  • [8] The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
    Bergamo, Alberta
    Dyson, Paul J.
    Sava, Gianni
    [J]. COORDINATION CHEMISTRY REVIEWS, 2018, 360 : 17 - 33
  • [9] Linking the future of anticancer metal-complexes to the therapy of tumour metastases
    Bergamo, Alberta
    Sava, Gianni
    [J]. CHEMICAL SOCIETY REVIEWS, 2015, 44 (24) : 8818 - 8835
  • [10] Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity
    Betanzos-Lara, Soledad
    Novakova, Olga
    Deeth, Robert J.
    Pizarro, Ana M.
    Clarkson, Guy J.
    Liskova, Barbora
    Brabec, Viktor
    Sadler, Peter J.
    Habtemariam, Abraha
    [J]. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2012, 17 (07): : 1033 - 1051